10/30/24 16:35 | 10/28/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -1,491 | 9.44 | 0 | -158 | -3 | 5,653 | M | | | | | | | | | | | | | | |
9/24/24 16:40 | 9/20/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S | -7,395 | 6.53 | 0 | -1,133 | -14 | 7,197 | D | | | | | | | | | | | | | | |
9/13/24 18:44 | 9/11/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -3,405 | 6.00 | 0 | -567 | -6 | 8,330 | D | | | | | | | | | | | | | | |
7/9/24 16:15 | 7/5/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Dunn Edmund | MA | O | Principa | S | -6 | 3.83 | 0 | -2 | -10 | 14 | D | | | | | | | | | | | | | | |
6/5/24 16:10 | 6/3/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Dunn Edmund | MA | O | Principa | S | -5 | 4.04 | 0 | -1 | -7 | 16 | D | | | | | | | | | | | | | | |
6/30/21 18:09 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Yang Rick | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:08 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Walker Paul Edward | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:08 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Sonsini Peter W. | CA | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:07 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Sandell Scott D | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:06 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Mathers Edward T | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:06 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Makower Joshua | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:05 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Makhzoumi Mohamad | CA | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:04 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Landsman Liza | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:02 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Florence Anthony A. Jr. | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:02 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Chang Carmen | CA | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:01 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Behbahani Ali | MD | DT | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 18:00 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Baskett Forest | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | I | | | | | | | | | | | | | | |
6/30/21 17:59 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | New Enterprise Associates 17, L.P. | MD | T | | P.d | 19,950 | 19.00 | 0 | 1,050 | 16 | 7,692 | D | | | | | | | | | | | | | | |
6/30/21 17:05 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | P.d | 3,000 | 19.00 | 0 | 158 | 2 | 8,897 | I | | | | | | | | | | | | | | |
6/30/21 17:00 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | P.d | 3,000 | 19.00 | 0 | 158 | 2 | 8,897 | M | | | | | | | | | | | | | | |
6/30/21 16:08 | 6/28/21 | GLUE | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 11,400 | 19.00 | 0 | 600 | 23 | 3,202 | I | | | | | | | | | | | | | | |